WHO ICTRP trial

Clinical study on applicability of homoeopathic medicine Tarentula hispanica in…

CTRI/2024/07/070244 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/07/070244
Public title Clinical study on applicability of homoeopathic medicine Tarentula hispanica in symptoms of Attention Deficit Hyperactivity Disorder with synthesis repertory
Scientific title Clinical Verification of Rubrical Representation of Attention Deficit Hyperactivity Disorder related symptoms of Tarentula hispanica in Synthesis Repertory - NIL
Primary sponsor Sarada Krishna Homoeopathic Medical College
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3/ Phase 4
Countries India
Conditions Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type
Interventions Intervention1: Tarentula hispanica: Homoeopathic medicine Tarentula hispanica will be prescribed. Daily one dose of medicine will be administered orally. Follow-up of the case will be observed once in every 15 days.The research will be done…
Registration date Sep 7, 2024
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations